Stock listing

A3D54P Stock Price, News, Filings & Events — Corbus Pharmaceuticals Holdings, Inc.

Selected listing: A3D54P · LS · EUR · DE

This page tracks Corbus Pharmaceuticals Holdings, Inc.'s A3D54P:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A3D54P:LS. A3D54P:LS is the stock-level entry point for investors researching Corbus Pharmaceuticals Holdings, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Corbus Pharmaceuticals Holdings, Inc. (Ticker: CRBP) is a public company based in the United States, with a market capitalization of approximately $166.9 million. The company focuses on developing innovative therapies for rare and serious diseases. Corbus is committed to advancing its clinical programs and expanding its portfolio to address unmet medical needs.

A3D54P:LSEURDEUpdated August 14, 2026
Corbus Pharmaceuticals Holdings, Inc. logo
Ticker
A3D54P:LS
Asset type
Stock
Market cap
$195.2M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
LS
Currency
EUR

Corbus Pharmaceuticals Holdings, Inc. A3D54P:LS stock context

This page tracks Corbus Pharmaceuticals Holdings, Inc.'s A3D54P:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A3D54P:LS. A3D54P:LS is the stock-level entry point for investors researching Corbus Pharmaceuticals Holdings, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Corbus Pharmaceuticals Holdings, Inc. (Ticker: CRBP) is a public company based in the United States, with a market capitalization of approximately $166.9 million. The company focuses on developing innovative therapies for rare and serious diseases. Corbus is committed to advancing its clinical programs and expanding its portfolio to address unmet medical needs.

Research Corbus Pharmaceuticals Holdings, Inc.

Alternate listings